Claims
- 1. A two part peritoneal dialysis solution designed to be mixed prior to infusion into a patient comprising:a first part housed in a first structure including dextrose; a second part housed in a second structure including approximately 0.25 to about 4.0% (w/v) polypeptides; and including in either the first or the second structure a sufficient amount of the following ingredients so when the first part and second part are mixed, the following is provided: 120 to about 150 (mEq/L) sodium; 80.0 to about 110.0 (mEq/L) chloride; 0.0 to about 5.0 (mEq/L) lactate; 0.0 to about 45.0 (mEq/L) bicarbonate; 0.0 to about 4.0 (mEq/L) calcium; and 0.0 to about 4.0 (mEq/L) magnesium, wherein not more than approximately 0.10% of the polypeptides has a molecular weight of greater than 1200, not more than approximately 25% of the polypeptides has a molecular weight of less than 400, and the weight average of polypeptides is within the range of approximately 400 to about 900 daltons.
- 2. A two part peritoneal dialysis solution designed to be mixed prior to infusion into a patient comprising:a first part housed in a first structure including dextrose; a second part housed in a second structure including approximately 0.25 to about 8.0% (w/v) polypeptides having a molecular weight average of approximately 400 to about 900 daltons; and including in either the first or the second structure a sufficient amount of the following ingredients so when the first part and second part are mixed, the following is provided: 120 to about 150 (mEq/L) sodium; 80.0 to about 110.0 (mEq/L) chloride; 0.0 to about 5.0 (mEq/L) lactate; 0.0 to about 45.0 (mEq/L) bicarbonate; 0.0 to about 4.0 (mEq/L) calcium; and 0.0 to about 4.0 (mEq/L) magnesium, wherein the first and second structures are two separate chambers of a single container.
- 3. A two part peritoneal dialysis solution designed to be mixed prior to infusion into a patient comprising:a first part housed in a first structure, the first part including approximately 1.0 to about 8% (w/v) dextrose and a pH of approximately 4.0 to about 5.5; a second part housed in a second structure, the second part including approximately 0.5 to about 8.0% (w/v) polypeptides and a pH of approximately 6.0 to about 7.5 wherein not more than approximately 0.10% of the polypeptides have a molecular weight of greater than 1200, wherein not more than approximately 25% of the polypeptides have a molecular weight of less than 400, and wherein the weight average of polypeptides is within the range of approximately 400 to about 900 daltons; and including in either the first or the second structure a sufficient amount of the following ingredients so when the first part and second part are mixed, the following is provided: 120 to about 150 (mEq/L) sodium; 80.0 to about 110.0 (mEq/L) chloride; 0.0 to about 5.0 (mEq/L) lactate; 0.0 to about 45.0 (mEq/L) bicarbonate; 0.0 to about 4.0 (mEq/L) calcium; and 0.0 to about 4.0 (mEq/L) magnesium.
Parent Case Info
This application is a divisional of application Ser. No. 07/995,106, filed Dec. 22, 1992 now U.S. Pat. No. 6,380,163.
US Referenced Citations (25)
Foreign Referenced Citations (3)
Number |
Date |
Country |
0 076 355 |
Apr 1983 |
EP |
0 153 164 |
Aug 1985 |
EP |
0 218 900 |
Jan 1992 |
EP |
Non-Patent Literature Citations (6)
Entry |
English Abstract of WO 93/19792.* |
English Abstract of EP 0,399,549.* |
English Abstract of EP 0,431,465.* |
English Abstract of EP 0,170,275.* |
English Abstract of EP 0564672.* |
English Abstract of EP 0277868. |